| 1 |
Ian Philip Butler Ingham |
Tonejet Limited |
3 |
| 1 |
Eliad Perpinyal |
— |
3 |
| 3 |
Paul Francis McKee |
British Telecommunications Public Limited |
2 |
| 3 |
Christopher Grimes |
— |
2 |
| 3 |
Thomas Harle |
Endress+Hauser Wetzer Gmbh+Co. Kg |
2 |
| #6 |
Oliver Maynard |
— |
1 |
| #6 |
Janusz Jozef Kulagowski |
Merck |
1 |
| #6 |
Russell M. Thompson |
Infineum International Limited |
1 |
| #6 |
Mark R. Buckingham |
3M |
1 |
| #6 |
Kim Louise Hirst |
Astex Therapeutics Limited |
1 |
| #6 |
Ashley Rolfe |
— |
1 |
| #6 |
Jack Philip Boad |
IBM |
1 |
| #6 |
Samuel Edward Mann |
Johnson & Johnson |
1 |
| #6 |
David Wyn Watson |
Astrazeneca Ab |
1 |
| #6 |
Arwel Lewis |
Astex Therapeutics Limited |
1 |
| #6 |
Jehanzeb Ahmed |
Keymed (Medical & Industrial Equipment) Limited |
1 |
| #6 |
Stephen Rawlings |
Illumina Cambridge Limited |
1 |
| #6 |
Jamie Mark Shedley |
— |
1 |
| #6 |
Guy Edward Shelverton |
Esab Ab |
1 |
| #6 |
James P. Gregson |
Dana-Farber Cancer Institute |
1 |
| #6 |
Stuart William Andrews |
E2V Technologies (Uk) Limited |
1 |
| #6 |
Kanza Amanullah |
John Crane Uk Limited |
1 |
| #6 |
Colin Gratton |
Nicoventures Holdings Limited |
1 |
| #6 |
Dale Robert Mitchell |
Astex Therapeutics Limited |
1 |
| #6 |
Hui Wu |
Reuters Limited |
1 |
| #6 |
Patrick Fox-Roberts |
Snap |
1 |